Evaluation of the MYNX CONTROL™ Arterial Closure System for Achieving Primary Hemostasis after Arterial Femoral Access Following Peripheral Arterial Interventions, Compared to the FemoSealTM Closure System.

Background: In addition to manual compression, various vascular closure devices (VCD) are available to seal the puncture site following arterial vascular procedures. Purpose: To evaluate the efficacy and safety of the extravascular MYNX CONTROL closure system for achieving primary hemostasis after femoral arterial access following peripheral arterial procedures, compared to the intravascular FemoSeal Aclosure system. Patients and Methods: A retrospective analysis of consecutive patients who underwent endovascular intervention between April and November 2022 was performed. The primary endpoint was the incidence of significant puncture site complication defined as a complication resulting in medical treatment. Secondary endpoints included peri-interventional incidence of hematoma, peri-interventional changes in hemoglobin, incidence of emergency diagnostics and predictors for closure system failure. Results: Five hundred and forty-eight patients were included in this analysis. False aneurysm occurred in 18/273 cases (6.6%) following the use of the MYNX closure system, compared to 6/275 cases after using the FemoSeal closure system (2.2%, p = 0.006). The incidence of post-interventional hematoma was not significantly different (28 (10.3%) in the MYNX group versus 32 (11.6%) in the FemoSeal group, p = 0.358). Peri-interventional hemoglobin drop did not differ between groups (p = 0.449). Emergency diagnostics were not significantly performed more often in the MYNX group (14 (5.1%) versus 8 (2.9%), p = 0.134). A post-interventional duplex sonography showed stenosis at the puncture site in one patient after use of the MYNX system. For the entire cohort, oral anticoagulation was the only predictor for the failure of the closure device (p = 0.036). Conclusions: Device failure was more common after using the extravascular MYNX CONTROL system than after using the intravascular FemoSeal system. However, the need for surgical or interventional therapy due to device failure was low.

Semi-crystalline microplastics in wastewater plant effluents and removal efficiencies of post-treatment filtration systems.

Microplastics (MPs) are ubiquitous in the environment and have been found in every environmental compartment. Wastewater and wastewater treatment plants (WWTPs) have been identified as possible point sources contributing to the emission of microplastic particles (MPP) into the aquatic environment. So far, MPP in wastewater effluents have mainly been analyzed by spectroscopic methods resulting in concentrations as number per volume. In this study, we present mass concentrations in the secondary effluents of four German municipal WWTPs, removal efficiencies of seven post-treatment systems and the resulting load emissions. Differential Scanning Calorimetry (DSC) was used for the analysis of semi-crystalline MPs. The concentrations of secondary effluents ranged from 0.1 to 19.6 µg L-1. Removal efficiencies > 94% were found for a microfiltration membrane (MF), two cloth types of a pile cloth media filter (PCMF), a micro strainer, a discontinuous downflow granulated activated carbon filter (GAC) and a powdered activated carbon (PAC) stage with clarifier and rapid sand filtration. A rapid sand filter (RSF) at WWTP B showed a removal efficiency of 82.38%. Only a continuous upflow GAC filter at WWTP C proved to be unsuitable for MP removal with an average removal efficiency of 1.9%.